Enimmune (ROCO:6564) YoY EBITDA Growth : 59.14% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Enimmune YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Enimmune's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 59.14%.

Enimmune's EBITDA per Share for the six months ended in Dec. 2024 was NT$-0.92.

Enimmune YoY EBITDA Growth Historical Data

The historical data trend for Enimmune's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enimmune YoY EBITDA Growth Chart

Enimmune Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-9.31

49.20

-533.07

13.86

37.48

Enimmune Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial												-233.47	49.59	-38.49	-3.98	59.14

Enimmune YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Enimmune's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-2.175	-	-3.479)	/	\| -3.479 \|
=	37.48 %

Enimmune's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.919	-	-2.249)	/	\| -2.249 \|
=	59.14 %

Enimmune YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Enimmune's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Enimmune Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enimmune Corp (ROCO:6564) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dunhua South Road, 18th Floor-2, No. 76, Section 2, Da’an District, Taipei, TWN, 10683

Website

http://www.enimmune.com.tw

Enimmune Corp is primarily engaged in the research and development and trading of vaccines, testing reagents and biotechnology services, etc., as well as trading of related western medicines.

Enimmune Headlines

No Headlines